These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 12869294

  • 1. Prevention and treatment of osteoporosis in primary care offices.
    Gill JM, Hoffman MK.
    J Womens Health (Larchmt); 2003 Jun; 12(5):473-80. PubMed ID: 12869294
    [Abstract] [Full Text] [Related]

  • 2. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S, Dragomir A, Desgagné A, Blais L, Rossignol M, Blouin J, Moride Y, Ste-Marie LG, Fernandès JC.
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [Abstract] [Full Text] [Related]

  • 3. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [Abstract] [Full Text] [Related]

  • 4. Initiation of osteoporosis treatment after bone mineral density testing.
    Pressman A, Forsyth B, Ettinger B, Tosteson AN.
    Osteoporos Int; 2001 Apr; 12(5):337-42. PubMed ID: 11444079
    [Abstract] [Full Text] [Related]

  • 5. Management of postmenopausal osteoporosis for primary care.
    Miller P, Lukert B, Broy S, Civitelli R, Fleischmann R, Gagel R, Khosla S, Lucas M, Maricic M, Pacifici R, Recker R, Sarran HS, Short B, Short MJ.
    Menopause; 1998 Apr; 5(2):123-31. PubMed ID: 9689207
    [Abstract] [Full Text] [Related]

  • 6. Attitudes and beliefs of family physicians and gynecologists in relation to the prevention and treatment of osteoporosis.
    Suarez-Almazor M, Homik JE, Messina D, Davis P.
    J Bone Miner Res; 1997 Jul; 12(7):1100-7. PubMed ID: 9200010
    [Abstract] [Full Text] [Related]

  • 7. Hormone replacement therapy in postmenopausal women: utilization of health care resources by new users.
    Thorp JM, Gavin NI, Ohsfeldt RL.
    Am J Obstet Gynecol; 2001 Aug; 185(2):318-26. PubMed ID: 11518885
    [Abstract] [Full Text] [Related]

  • 8. Access to osteoporosis treatment is critically linked to access to dual-energy x-ray absorptiometry testing.
    Cadarette SM, Gignac MA, Jaglal SB, Beaton DE, Hawker GA.
    Med Care; 2007 Sep; 45(9):896-901. PubMed ID: 17712261
    [Abstract] [Full Text] [Related]

  • 9. Impact of medication adherence on health care utilization and productivity: self-reported data from a cohort of postmenopausal women on osteoporosis therapy.
    Wade SW, Satram-Hoang S, Nadkar A, Macarios D, Tosteson AN.
    Clin Ther; 2011 Dec; 33(12):2006-15. PubMed ID: 22099387
    [Abstract] [Full Text] [Related]

  • 10. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
    Barrett-Connor E, Wehren LE, Siris ES, Miller P, Chen YT, Abbott TA, Berger ML, Santora AC, Sherwood LM.
    Menopause; 2003 Dec; 10(5):412-9. PubMed ID: 14501602
    [Abstract] [Full Text] [Related]

  • 11. Is BMD testing appropriate for all menopausal women?
    Kleerekoper M, Nelson DA.
    Int J Fertil Womens Med; 2005 Dec; 50(2):61-6. PubMed ID: 16334412
    [Abstract] [Full Text] [Related]

  • 12. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.
    Andrade SE, Majumdar SR, Chan KA, Buist DS, Go AS, Goodman M, Smith DH, Platt R, Gurwitz JH.
    Arch Intern Med; 2003 Sep 22; 163(17):2052-7. PubMed ID: 14504118
    [Abstract] [Full Text] [Related]

  • 13. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
    Rasu RS, Shenolikar RA, Nahata MC, Balkrishnan R.
    Clin Ther; 2005 Dec 22; 27(12):1970-9. PubMed ID: 16507384
    [Abstract] [Full Text] [Related]

  • 14. [Postmenopausal osteoporosis].
    László A.
    Orv Hetil; 2004 Jan 04; 145(1):3-13. PubMed ID: 15222134
    [Abstract] [Full Text] [Related]

  • 15. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A.
    Ann Acad Med Stetin; 2003 Jan 04; 49():111-30. PubMed ID: 15552843
    [Abstract] [Full Text] [Related]

  • 16. Compliance with osteoporosis treatment guidelines in postmenopausal women.
    Mountjoy CR, Shrader SP, Ragucci KR.
    Ann Pharmacother; 2009 Feb 04; 43(2):242-50. PubMed ID: 19196838
    [Abstract] [Full Text] [Related]

  • 17. [Factors associated with calcium, vitamin D supplements intake and use of hormonal replacement therapy in health workers postmenopausal women].
    Zonana-Nacach A, Armenta-Rivera OT.
    Gac Med Mex; 2007 Feb 04; 143(4):291-6. PubMed ID: 17969836
    [Abstract] [Full Text] [Related]

  • 18. Understanding and preventing osteoporosis.
    Renfro J, Brown JB.
    AAOHN J; 1998 Apr 04; 46(4):181-91; quiz 192-3. PubMed ID: 9668725
    [Abstract] [Full Text] [Related]

  • 19. Osteoporosis pharmacotherapy and counseling services in US ambulatory care clinics: opportunities for multidisciplinary interventions.
    Teschemaker A, Lee E, Xue Z, Wutoh AK.
    Am J Geriatr Pharmacother; 2008 Dec 04; 6(5):240-8. PubMed ID: 19161926
    [Abstract] [Full Text] [Related]

  • 20. Osteoporosis prevention counseling during health maintenance examinations.
    Schrager S, Plane MB, Mundt MP, Stauffacher EA.
    J Fam Pract; 2000 Dec 04; 49(12):1099-103. PubMed ID: 11132059
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.